158 related articles for article (PubMed ID: 34657224)
1. Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.
Adolph JE; Fleischhack G; Gaab C; Mikasch R; Mynarek M; Rutkowski S; Schüller U; Pfister SM; Pajtler KW; Milde T; Witt O; Bison B; Warmuth-Metz M; Kortmann RD; Dietzsch S; Pietsch T; Timmermann B; Tippelt S;
J Neurooncol; 2021 Nov; 155(2):193-202. PubMed ID: 34657224
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study.
Adolph JE; Fleischhack G; Mikasch R; Zeller J; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S; Schüller U; von Hoff K; Obrecht D; Pietsch T; Pfister SM; Pajtler KW; Witt O; Witt H; Kortmann RD; Timmermann B; Krauß J; Frühwald MC; Faldum A; Kwiecien R; Bode U; Tippelt S
Neuro Oncol; 2021 Jun; 23(6):1012-1023. PubMed ID: 33331885
[TBL] [Abstract][Full Text] [Related]
3. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
4. Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study.
Gururangan S; Fangusaro J; Young Poussaint T; Onar-Thomas A; Gilbertson RJ; Vajapeyam S; Gajjar A; Goldman S; Friedman HS; Packer RJ; Boyett JM; Kun LE; McLendon R
Neuro Oncol; 2012 Nov; 14(11):1404-12. PubMed ID: 23019233
[TBL] [Abstract][Full Text] [Related]
5. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.
Merchant TE; Jenkins JJ; Burger PC; Sanford RA; Sherwood SH; Jones-Wallace D; Heideman RL; Thompson SJ; Helton KJ; Kun LE
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):52-7. PubMed ID: 12007941
[TBL] [Abstract][Full Text] [Related]
6. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Grundy RG; Wilne SA; Weston CL; Robinson K; Lashford LS; Ironside J; Cox T; Chong WK; Campbell RH; Bailey CC; Gattamaneni R; Picton S; Thorpe N; Mallucci C; English MW; Punt JA; Walker DA; Ellison DW; Machin D;
Lancet Oncol; 2007 Aug; 8(8):696-705. PubMed ID: 17644039
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
Rudà R; Bosa C; Magistrello M; Franchino F; Pellerino A; Fiano V; Trevisan M; Cassoni P; Soffietti R
Neuro Oncol; 2016 Feb; 18(2):261-8. PubMed ID: 26323606
[TBL] [Abstract][Full Text] [Related]
8. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91.
Timmermann B; Kortmann RD; Kühl J; Meisner C; Slavc I; Pietsch T; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):287-95. PubMed ID: 10661334
[TBL] [Abstract][Full Text] [Related]
9. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
10. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
[TBL] [Abstract][Full Text] [Related]
11. Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92.
Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Dieckmann K; Meisner C; Bamberg M
Radiother Oncol; 2005 Dec; 77(3):278-85. PubMed ID: 16300848
[TBL] [Abstract][Full Text] [Related]
12. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Grill J; Le Deley MC; Gambarelli D; Raquin MA; Couanet D; Pierre-Kahn A; Habrand JL; Doz F; Frappaz D; Gentet JC; Edan C; Chastagner P; Kalifa C;
J Clin Oncol; 2001 Mar; 19(5):1288-96. PubMed ID: 11230470
[TBL] [Abstract][Full Text] [Related]
13. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.
Benesch M; Weber-Mzell D; Gerber NU; von Hoff K; Deinlein F; Krauss J; Warmuth-Metz M; Kortmann RD; Pietsch T; Driever PH; Quehenberger F; Urban C; Rutkowski S
J Neurosurg Pediatr; 2010 Aug; 6(2):137-44. PubMed ID: 20672934
[TBL] [Abstract][Full Text] [Related]
14. Treatment with oral etoposide for childhood recurrent ependymomas.
Sandri A; Massimino M; Mastrodicasa L; Sardi N; Bertin D; Basso ME; Todisco L; Paglino A; Perilongo G; Genitori L; Valentini L; Ricardi U; Gandola L; Giangaspero F; Madon E
J Pediatr Hematol Oncol; 2005 Sep; 27(9):486-90. PubMed ID: 16189442
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
17. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in intracranial ependymomas in children.
Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
[TBL] [Abstract][Full Text] [Related]
20. mTORC1 activation in childhood ependymoma and response to sirolimus.
Bowers DC; Kucejova B; Margraf L; Gargan L; Brugarolas J
J Neurooncol; 2011 Jul; 103(3):797-801. PubMed ID: 21076853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
